Arcturus Therapeutics Stock Price

-0.18 (-1.12%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,814,509
Bid Price 15.75
Ask Price 15.85
News (1)
Day High 16.58


52 Week Range


Day Low 15.03
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Arcturus Therapeutics Holdings Inc ARCT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.18 -1.12% 15.84 19:16:59
Open Price Low Price High Price Close Price Prev Close
16.43 15.03 16.58 16.14 16.02
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,585 1,814,509 $ 15.70 $ 28,481,462 - 11.70 - 64.9735
Last Trade Time Type Quantity Stock Price Currency
18:43:10 formt 100 $ 15.84 USD


Draw Mode:

Arcturus Therapeutics Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 418.48M 26.42M 17.04M $ 12.36M $ - -7.74 -2.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 9.20%

more financials information »

Arcturus Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARCT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week12.5316.5812.5314.441,523,9923.3126.42%
1 Month16.9121.1511.7015.95881,649-1.07-6.33%
3 Months27.1631.414811.7019.36761,409-11.32-41.68%
6 Months39.6641.0611.7022.32628,034-23.82-60.06%
1 Year34.4564.973511.7034.84680,738-18.61-54.02%
3 Years9.67129.718.4946.17648,6596.1763.81%
5 Years10.06129.714.1144.90441,1945.7857.46%

Arcturus Therapeutics Description

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.

Your Recent History
Arcturus T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.